Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06568432
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-21
Brief Title:
Effect of C-reactive Protein Point-of-care Testing on Antibiotic Prescribing for Acute Respiratory-tract Infections At Primary Care Facilities in Rural China
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effect of C-reactive Protein Point-of-care Testing on Antibiotic Prescribing for Acute Respiratory-tract Infections At Primary Care Facilities in Rural China a Cluster-randomised Controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Our study was a practical cluster-randomized controlled trial to evaluate the impact of C-reactive protein point-of-care testing CRP POCT on antibiotic prescribing in patients with acute respiratory-tract infections ARI aged 1 to 75 years at primary care facilities in rural China
Detailed Description:
Our study was a practical cluster-randomized controlled trial to evaluate the impact of C-reactive protein point-of-care testing CRP POCT on antibiotic prescribing in patients with acute respiratory-tract infections ARI aged 1 to 75 years at primary care facilities in rural China The study includes two groups in which CRP POCT will be provided in 20 village clinics in the intervention group Additional physician training on the use of CRP POCT including centralized training distribution of physician training manuals and desk reminders and patient education sheets to help patients understand the help of CRP POCT in guiding their care will also be providedThe control group will not receive any intervention and will serve as the control usual care The primary outcome of this study was antibiotic prescribing rates defined as the proportion of outpatients aged 1 to 75 years who were diagnosed with ARI at the first visit to the village clinic and were prescribed at least one antibiotic among all ARI patients in the intervention and control groups between the start of the intervention and 6 months of follow-up
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None